Winship & Cleveland Clinic receive NCI award to establish center to improve radiation-based combination therapies

UCLA’s Luca Valle receives $2.1M grant from VA to improve prediction of radiorecurrent prostate cancer outcomes

Luca Valle, assistant professor of radiation oncology at the David Geffen School of Medicine at UCLA, was awarded a $2.1 million grant from the U.S. Department of Veterans Affairs to develop new methods to better understand the clinical scope and biological factors that lead to prostate cancer coming back after radiation therapy.

October 25, 2024

Vol.50 No.40

Clinical Roundup

ASTRO updates guideline on radiation therapy for HPV-related throat cancer

The American Society for Radiation Oncology published an updated clinical guideline in Practical Radiation Oncology that details best practices for using radiation therapy to treat patients who have oropharyngeal squamous cell carcinoma caused by the human papilloma virus.

June 21, 2024

Vol.50 No.25

Clinical Roundup

Cosylab, Mayo Clinic collaborate to advance radiation therapy, support the first carbon ion treatment facility in the U.S.

Cosylab, a provider of control systems and software solutions for complex and precise machines, has entered into a collaboration with Mayo Clinic to advance cancer care in the United States and beyond.

June 14, 2024

Vol.50 No.24

Clinical

Indefinite course of osimertinib dramatically improves PFS in stage 3 EGFR-mutated NSCLC

Treatment with an indefinite course of osimertinib dramatically improves progression-free survival for patients with stage 3 non-small cell cancer, according to the results of the LAURA trial. The median PFS was 39.1 months in the osimertinib group, compared to 5.6 months with the placebo group.

June 07, 2024

Vol.50 No.23

By Jacquelyn Cobb and McKenzie Prillaman

Clinical Roundup

Radiation before mastectomy cuts time delays for reconstructive surgery in breast cancer patients

Researchers at MD Anderson Cancer Center showed that altering the sequence of breast cancer treatment to administer radiation before mastectomy allowed for concurrent breast reconstruction surgery, which reduced the number of operations required, minimized treatment delays, and improved patient satisfaction.

April 12, 2024

Vol.50 No.15

Clinical Roundup

UCLA study: High-dose radiotherapy + chemo effective in treating NSCLC

A study led by researchers from the UCLA Health Jonsson Comprehensive Cancer Center showed that using high doses of radiation while integrating an ablative radiotherapy technique called stereotactic ablative radiotherapy concurrently with chemotherapy is safe and effective in treating people with locally advanced non-small cell lung cancer that is not suitable for surgery.

January 19, 2024

Vol.50 No.03

Winship & Cleveland Clinic receive NCI award to establish center to improve radiation-based combination therapies

YOU MAY BE INTERESTED IN

UCLA’s Luca Valle receives $2.1M grant from VA to improve prediction of radiorecurrent prostate cancer outcomes

ASTRO updates guideline on radiation therapy for HPV-related throat cancer

Cosylab, Mayo Clinic collaborate to advance radiation therapy, support the first carbon ion treatment facility in the U.S.

Indefinite course of osimertinib dramatically improves PFS in stage 3 EGFR-mutated NSCLC

Radiation before mastectomy cuts time delays for reconstructive surgery in breast cancer patients

UCLA study: High-dose radiotherapy + chemo effective in treating NSCLC

Renew today!

Subscriber content

Never miss an issue!

Login